Health and Fitness Health and Fitness
Wed, March 30, 2011
Tue, March 29, 2011
Mon, March 28, 2011
Sun, March 27, 2011
Fri, March 25, 2011
Thu, March 24, 2011
Wed, March 23, 2011
Tue, March 22, 2011
Mon, March 21, 2011
[ Mon, Mar 21st 2011 ] - Market Wire
30 p.m. ET
Sun, March 20, 2011
Fri, March 18, 2011
Thu, March 17, 2011
Wed, March 16, 2011
Tue, March 15, 2011
Mon, March 14, 2011
Sun, March 13, 2011
Sat, March 12, 2011
Fri, March 11, 2011
[ Fri, Mar 11th 2011 ] - Market Wire
Covidien????????????????FDA??
Thu, March 10, 2011
Wed, March 9, 2011
Tue, March 8, 2011

GenMark Receives Medical Device Manufacturing License for its Carlsbad Facility


//health-fitness.news-articles.net/content/2011/ .. facturing-license-for-its-carlsbad-facility.html
Published in Health and Fitness on Thursday, March 17th 2011 at 10:20 GMT by Market Wire   Print publication without navigation


CARLSBAD, Calif.--([ BUSINESS WIRE ])--GenMark Diagnostics (Nasdaq:GNMK)today advised it has received notice from the California State Food and Drug Branch, that following a recent audit of its new Carlsbad facility, it has been issued with a medical device manufacturing license, enabling the company to manufacture and distribute all its existing and future products from this facility. All operations at its Pasadena facility, which had been the source of all manufacturing and distribution for the company, will cease at the end of March 2011.

ABOUT GENMARK

GenMark, a provider of automated, multiplex molecular diagnostic testing systems, detects and measures DNA and RNA targets to diagnose disease and to optimize the treatment of patients and is focused on developing and commercializing its eSensor detection technology. GenMark's XT-8 System is designed to support a broad range of molecular diagnostic tests with a compact and easy-to-use workstation and self-contained, disposable test cartridges. GenMark has developed five diagnostic tests for use with the XT-8 System, including its Cystic Fibrosis Genotyping Test, Warfarin Sensitivity Test and Thrombophilia Risk Test which have received clearance from the Food and Drug Administration.


Publication Contributing Sources